Angiomax Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Bivalirudin in Late PCI for STEMI
Condition:   we Focuse on the Efficiency and Safety for Bivalirudin as the Anticoagulation Therapy During Late PCI Interventions:   Drug: Bivalirudin;   Drug: Heparin Sponsor:   Second Xiangya Hospital of Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials

Bivalirudin in Late PCI for Oatients With STEMI
Condition:   we Focuse on the Efficiency and Safety of Bivalirudin During Late PCI Interventions:   Drug: Bivalirudin;   Drug: Heparin Sponsor:   Second Xiangya Hospital of Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials

Bivalirudin in Late PCI for Oatients With STEMI
Condition:   STEMI - ST Elevation Myocardial Infarction Interventions:   Drug: Bivalirudin;   Drug: Heparin Sponsor:   Second Xiangya Hospital of Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials